- Home
- AIRT vs IMRX Comparison
AIRT vs IMRX Comparison
Compare AIRT & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIRT
- IMRX
- Stock Information
- Founded
- AIRT 1980
- IMRX 2008
- Country
- AIRT United States
- IMRX United States
- Employees
- AIRT N/A
- IMRX N/A
- Industry
- AIRT Air Freight/Delivery Services
- IMRX Biotechnology: Pharmaceutical Preparations
- Sector
- AIRT Consumer Discretionary
- IMRX Health Care
- Exchange
- AIRT Nasdaq
- IMRX Nasdaq
- Market Cap
- AIRT 54.3M
- IMRX 62.7M
- IPO Year
- AIRT N/A
- IMRX 2021
- Fundamental
- Price
- AIRT $20.20
- IMRX $2.02
- Analyst Decision
- AIRT
- IMRX Buy
- Analyst Count
- AIRT 0
- IMRX 7
- Target Price
- AIRT N/A
- IMRX $12.80
- AVG Volume (30 Days)
- AIRT 14.1K
- IMRX 4.9M
- Earning Date
- AIRT 02-10-2025
- IMRX 02-28-2025
- Dividend Yield
- AIRT N/A
- IMRX N/A
- EPS Growth
- AIRT N/A
- IMRX N/A
- EPS
- AIRT N/A
- IMRX N/A
- Revenue
- AIRT $284,091,000.00
- IMRX N/A
- Revenue This Year
- AIRT N/A
- IMRX N/A
- Revenue Next Year
- AIRT N/A
- IMRX N/A
- P/E Ratio
- AIRT N/A
- IMRX N/A
- Revenue Growth
- AIRT N/A
- IMRX N/A
- 52 Week Low
- AIRT $14.02
- IMRX $1.00
- 52 Week High
- AIRT $30.60
- IMRX $7.68
- Technical
- Relative Strength Index (RSI)
- AIRT 51.54
- IMRX 47.82
- Support Level
- AIRT $18.85
- IMRX $1.84
- Resistance Level
- AIRT $20.51
- IMRX $3.80
- Average True Range (ATR)
- AIRT 0.71
- IMRX 0.29
- MACD
- AIRT -0.07
- IMRX -0.03
- Stochastic Oscillator
- AIRT 66.83
- IMRX 9.18
About AIRT Air T Inc.
Air T Inc together with its subsidiaries provides air freight service to the express delivery industry. The company's operating segments include Overnight air cargo, Ground equipment sales, Commercial jet engines, and parts, Corporate, and Others. The company generates maximum revenue from the Commercial Jet Engines and Parts segment.
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.